Otsuka Completes $700M Acquisition of Transcend Therapeutics to Expand PTSD Pipeline

Otsuka America, Inc., a subsidiary of Otsuka Pharmaceutical Co., Ltd., has completed its acquisition of Transcend Therapeutics, a clinical-stage biotechnology... Read More

The post Otsuka Completes $700M Acquisition of Transcend Therapeutics to Expand PTSD Pipeline appeared first on citybiz.